HES patients with a FIP1L1-PDGFRA rearrangement are now reclassified as chronic eosinophilic leukemia (CEL), as this gene has become a marker of disease clonality [60]. Here, PDGFRA is linked to Chronic Eosinophilic Leukemia, Not Otherwise Specified.